ArchBjing® Single-Use Intracardiac Echocardiography Catheter by IceCrystal Intelligence Featured in Artery Innovation Showcase Episode 135

Epidemiological surveys indicate that the prevalence of atrial fibrillation (AF) in China is approximately 1.5%, with a cumulative total of over 20 million AF patients nationwide. In recent years, with the continuous advancement of medical technology in China, the number of interventional procedures for AF has grown rapidly: in 2024, more than 180,000 AF interventional procedures were performed in China, including nearly 30,000 left atrial appendage closure (LAAC) procedures.

In interventional procedures for atrial fibrillation, transseptal puncture remains the most cautiously performed step by electrophysiologists due to its complex anatomy, high precision requirements, and risk of serious complications.

The ArchBjing® ICE (Intracardiac Echocardiography) catheter, independently developed by ICE Intelligent Healthcare Co., Ltd. (Suzhou), was approved for market launch in February 2025, breaking the monopoly of foreign companies in the intracardiac echocardiography field. The ArchBjing® ICE catheter features unique advantages such as an ultra-wide 120° sector view and a DSA interventional perspective. During procedures, it enables operators to obtain a broader surgical field of view, allowing for clear visualization of the spatial relationships between target anatomical structures, devices, and adjacent anatomy. While enhancing procedural safety and efficacy, the catheter significantly reduces manipulation requirements, thereby greatly improving operational efficiency.

On Friday, January 23, VCBeat invited Mr. Zhang Jihong, Founder and CEO of ICE, and Mr. Tang Xiaobo, Director of Marketing and Business Development at ICE, to present and share insights on the ArchBjing® Disposable Intracardiac Echocardiography Catheter.

ICE Intelligent Healthcare Co., Ltd. was established in October 2021, focusing on the field of interventional ultrasound imaging and specializing in Intracardiac Echocardiography (ICE) technology, which had long been monopolized by foreign companies. The company has achieved breakthroughs across the entire technological chain. Its ICE products demonstrate excellent performance in image quality and signal transmission, and received National Class III Medical Device Registration approval in February 2025, marking its entry into the commercialization phase. In the same year, it ranked first among domestic ICE products for hospital admissions in the Sichuan Provincial Centralized Procurement program, successfully breaking the long-standing monopoly of imported products. ICE technology is hailed as the "fluoroscopic eye" for interventional cardiologists, capable of real-time visualization of internal cardiac structures and catheter positions, thereby enhancing surgical precision and safety. This technology encompasses three major technical clusters and 14 interdisciplinary fields, presenting extremely high barriers to entry. The founding team boasts backgrounds from top-tier enterprises such as GE and Philips, with complementary core competencies, and continues to recruit high-end technical talent, forming an interdisciplinary team of nearly 80 members. Currently, the company operates a 3,000-square-meter production base in Suzhou and has established R&D centers in Wuhan and Chongqing, possessing comprehensive capabilities in both research and development and mass production.

ICE has launched clinical research collaborations with Beijing Anzhen Hospital and Fuwai Hospital, among others, and completed an A+ funding round exceeding RMB 100 million. With steady progress in operations and R&D, it has laid a solid foundation for the widespread adoption of domestically produced high-end interventional ultrasound equipment.

“VCBeat New Product Showcase” is a live-streaming series dedicated to supporting the launch of innovative products by healthcare companies. The program’s mission is to empower every milestone launch of innovative medical products. If your company has plans to launch an innovative medical product or achieve a significant milestone and wishes to participate in the “VCBeat New Product Showcase,” please add our assistant for consultation.